MoneyWorks4Me

Orchid Pharma - Quaterly Results

12 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 2444.06 millions rose by 33.61% from Rs. 1829.20 millions.The company almost doubled its revenue to Rs. 291.03 millions  from Rs. 107.75 millions in the quarter ended June 2024.Operating profit surged to 410.20 millions from the corresponding previous quarter of 240.28 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2444.06 1829.20 33.61 2444.06 1829.20 33.61 8193.68 6658.98 23.05
Other Income 77.72 18.86 312.09 77.72 18.86 312.09 303.89 194.30 56.40
PBIDT 410.20 240.28 70.72 410.20 240.28 70.72 1410.70 1030.49 36.90
Interest 34.73 55.45 -37.37 34.73 55.45 -37.37 163.28 322.26 -49.33
PBDT 375.47 184.83 103.14 375.47 184.83 103.14 1247.42 1100.33 13.37
Depreciation 84.44 77.08 9.55 84.44 77.08 9.55 332.19 547.87 -39.37
PBT 291.03 107.75 170.10 291.03 107.75 170.10 915.23 552.46 65.66
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -32.26 0.00 0.00
PAT 291.03 107.75 170.10 291.03 107.75 170.10 947.49 552.46 71.50
Equity 507.19 507.19 0.00 507.19 507.19 0.00 507.19 408.16 24.26
PBIDTM(%) 16.78 13.14 27.77 16.78 13.14 27.77 17.22 15.48 11.25
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..